Delta-3 Inhibitors
Delta-3 inhibitors, focusing on DLL3, primarily comprises compounds that target the Notch signaling pathway, particularly through the inhibition of γ-secretase, a key enzyme in Notch receptor processing. These inhibitors, such as DAPT, LY-411575, RO4929097, and MK-0752, function by preventing the cleavage of the Notch receptor, a crucial step for the activation of Notch signaling. By doing so, they indirectly influence the activity of DLL3, as DLL3 is a ligand in this pathway. These compounds are essential in understanding the modulation of Notch signaling, which plays a critical role in cell differentiation and development.
Compounds like PF-03084014, L-685458, and BMS-708163 exhibit their inhibitory effects by altering the dynamics of Notch signaling, potentially affecting the regulatory mechanisms in which DLL3 is involved. Avagacestat, Semagacestat, and DBZ also follow this pattern, providing insight into the complex interplay within the Notch pathway. MRK-560 and Begacestat, similar to other γ-secretase inhibitors in this list, contribute to the modulation of DLL3 activity by impacting Notch pathway signaling.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
γ-secretase inhibitor; can indirectly inhibit DLL3 by blocking Notch receptor cleavage and signaling. | ||||||
LY411575 | 209984-57-6 | sc-364529 sc-364529A | 10 mg 50 mg | $198.00 $473.00 | 6 | |
Another γ-secretase inhibitor; potentially affects DLL3 by inhibiting Notch signaling activation. | ||||||
RO-4929097 | 847925-91-1 | sc-364602 sc-364602A | 10 mg 50 mg | $439.00 $1417.00 | 1 | |
γ-secretase inhibitor; may indirectly affect DLL3 activity through inhibition of the Notch pathway. | ||||||
MK-0752 | 471905-41-6 | sc-364534 sc-364534A | 10 mg 50 mg | $592.00 $1550.00 | ||
γ-secretase inhibitor; could modulate DLL3 activity by impacting Notch receptor processing. | ||||||
PF-3084014 | 1290543-63-3 | sc-507501 | 5 mg | $130.00 | ||
γ-secretase inhibitor; potentially impacts DLL3 by altering Notch signaling dynamics. | ||||||
L-685,458 | 292632-98-5 | sc-204042 sc-204042A | 1 mg 5 mg | $337.00 $1000.00 | 4 | |
Highly potent γ-secretase inhibitor; could indirectly influence DLL3 through Notch pathway modulation. | ||||||
BMS-708163 | 1146699-66-2 | sc-364444 sc-364444A | 10 mg 50 mg | $480.00 $1455.00 | 1 | |
γ-secretase inhibitor; might affect DLL3 by reducing Notch receptor cleavage. | ||||||
Semagacestat | 425386-60-3 | sc-364614 sc-364614A | 10 mg 50 mg | $350.00 $1200.00 | 1 | |
γ-secretase inhibitor; could indirectly influence DLL3 through its effects on Notch signaling. | ||||||